Sat.Nov 05, 2022 - Fri.Nov 11, 2022

article thumbnail

Expert: Deprescribing Is an Important Part of End-of-Life Care

Pharmacy Times

A session presenter at the ASCP 2022 Annual Meeting addresses research investigating the value of preventative treatments when patients have a limited life expectancy.

142
142
article thumbnail

A Culture of Quality: The Catalyst to Accelerate Innovation

PharmExec

Why enabling a shared culture of quality across an organization is key to maintaining pharma’s recent pace of innovation wins—while inspiring new levels of confidence.

99
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The legacy of Glen de Vries: Our last interview with the pioneering entrepreneur

PharmaVoice

Recorded just weeks before his passing, our sit-down interview with the legendary medical sciences entrepreneur showcased his passion for pushing the industry toward its next frontier

97
article thumbnail

AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments

Fierce Pharma

AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments. Thu, 11/10/2022 - 09:02

Vaccines 114
article thumbnail

Educating Patients with Chronic Kidney Disease Can Reduce Mortality Risk

Pharmacy Times

Active patient care with chronic kidney disease may provide enormous benefits for patients, the economy, and society.

article thumbnail

Digital Biomarkers Could Reshape CNS Diagnosis, Treatment

PharmExec

AI drives new signal-detection efforts in Alzheimer’s and ALS.

98
article thumbnail

Novo Nordisk’s quantum bet on ‘world changing’ computing

PharmaVoice

Behind the pharma giant’s plans to build the first quantum computer by 2034 to accelerate drug development

87

More Trending

article thumbnail

Study Finds Increase in Heart Disease Death Rates During COVID-19 Pandemic

Pharmacy Times

In 2020, heart disease death rates increased in adults across all age, sex, racial and ethnic groups, specifically among younger adults and non-Hispanic Black adults.

123
123
article thumbnail

Whole-Person Care: Are We Ready? The Intersection of Pharma and Digital Therapeutics

PharmExec

Senior leaders focused on the advancement of digital medicine and health meet to discuss the importance of these tools for life sciences companies, payers, and others in harnessing a healthcare future that will be increasingly dominated by holistic treatment and delivery.

72
article thumbnail

After numerous setbacks, here’s where the Huntington’s pipeline stands

PharmaVoice

A look at emerging treatments and where there’s hope for patients

87
article thumbnail

UnitedHealth continues to lead the way on insurer profits in Q3. Here's how its competitors fared

Fierce Healthcare

UnitedHealth continues to lead the way on insurer profits in Q3. Here's how its competitors fared. pminemyer. Mon, 11/07/2022 - 15:36

Insurance 101
article thumbnail

Expert Said Lupus Nephritis May be Treated with Lower Doses of Steroids

Pharmacy Times

Controlling blood pressure may be the most important type of treatment for vasculitis and lupus patients, said a professor of renal medicine at ASN Kidney Week in Orlando, Florida.

118
118
article thumbnail

First human trials of lab-grown red blood cells start in UK

Pharma Phorum

Blood cells grown in a laboratory have been given to people for the first time in a clinical trial being carried out by researchers in the UK, in the hope that plentiful supplies of rare blood groups can be manufactured to order.

100
100
article thumbnail

3 ways pharma can weather a recession

PharmaVoice

If “winter is coming” in the form of a recession, pharmas can take advantage of an inherent resiliency by crushing these three fundamentals

83
article thumbnail

GSK's CAR-T rival Blenrep fails multiple myeloma trial, endangering its accelerated approval

Fierce Pharma

GSK's CAR-T rival Blenrep fails multiple myeloma trial, endangering its accelerated approval. Mon, 11/07/2022 - 09:45

100
100
article thumbnail

Expert Panel Urges Clinicians to Get Involved With Public Health Issues

Pharmacy Times

In addition to the ongoing COVID-19 pandemic, significant public health concerns include opioid overdoses, maternal mortality disparities, and climate change.

117
117
article thumbnail

Cyagen and Neurophth partner to develop gene therapy vectors

Pharmaceutical Technology

Cyagen and Neurophth Therapeutics have entered a strategic partnership to jointly develop next-generation AAV gene therapy vectors for specific kinds of genetic ophthalmic ailments.

98
article thumbnail

This plant-based gel stops bleeding in seconds — and might have potential in drug delivery

PharmaVoice

29-year-old biotech founder Joe Landolina is hoping to capitalize on major possibilities in the human health market through his startup Cresolin and just inked a research partnership with Walter Reed

83
article thumbnail

Nurses plan to picket outside of 22 Kaiser Permanente locations

Fierce Healthcare

Nurses plan to picket outside of 22 Kaiser Permanente locations. fdiamond. Fri, 11/11/2022 - 09:08

96
article thumbnail

Study Shows Progress in Breast Cancer Survivorship Over 15 Years

Pharmacy Times

Study shows there are 2.5 times more breast cancer survivors since the last estimate was conducted in 2007.

114
114
article thumbnail

First needle-free COVID-19 vaccine patch

European Pharmaceutical Review

Vaxxas, a biotechnology company has announced the start of its Phase I clinical trial of a needle-free COVID-19 vaccine, delivered via a high-density microarray patch (HD-MAP), giving potential coverage of all major SARS-CoV-2 variants.

article thumbnail

Woman of the Week: 82VS’s Trier Bryant

PharmaVoice

Welcome to the Woman of the Week podcast, a weekly discussion that illuminates the unique stories of women leaders who are catalyzing change throughout the life sciences industry. You can check out all our podcast episodes here. Not every leader makes it their mission to go where the fire

83
article thumbnail

Walgreens' VillageMD inks $9B deal to buy Summit Health, marking largest physician deal of the year

Fierce Healthcare

Walgreens' VillageMD inks $9B deal to buy Summit Health, marking largest physician deal of the year. hlandi. Mon, 11/07/2022 - 11:57

97
article thumbnail

Defining Variants of Interest vs Variants of Concern

Pharmacy Times

Expert health professionals share their thoughts on variants of concern vs variants of interest of the SARS-CoV-2 strains as they relate to clinical practice.

114
114
article thumbnail

Moderna’s Spikevax carries higher risk of myocarditis than Pfizer's Comirnaty, study says

Fierce Pharma

Moderna’s Spikevax carries higher risk of myocarditis than Pfizer's Comirnaty, study says. zbecker. Tue, 11/08/2022 - 11:03

94
article thumbnail

Chasing that ‘Time magazine cover potential’

PharmaVoice

Rami Elghandour was already retired. Then CAR-T specialist Arcellx lured him back into the industry to try to change the world

83
article thumbnail

CMS looking at quality metrics to get ACA exchange plans into value-based care

Fierce Healthcare

CMS looking at quality metrics to get ACA exchange plans into value-based care. rking. Thu, 11/10/2022 - 16:00

96
article thumbnail

Review of the 2022 ACCE Guidelines for Non-Alcoholic Fatty Liver Disease

Pharmacy Times

The most common cause of death for patients with non-alcoholic fatty liver disease is cardiovascular disease, but it also increases the risk of hepatocellular carcinoma and may surpass hepatitis B and C as the leading cause of this cancer.

114
114
article thumbnail

Artificial Intelligence for better antibody drugs: ready for prime time?

Pharma Phorum

The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were mAbs and this trend is forecasted to remain the same over the next five years.

95
article thumbnail

While CAR-T wait times remain ‘heartbreaking,’ researchers push for innovations that could help

PharmaVoice

Facing an unprecedented manufacturing bottleneck, a new coalition is aiming to create the next generation of CAR-T therapies

83
article thumbnail

Providers urge Biden to tackle 'gridlocked' hospital EDs and life-threatening care delays

Fierce Healthcare

Providers urge Biden to tackle 'gridlocked' hospital EDs and life-threatening care delays. dmuoio. Wed, 11/09/2022 - 13:55

article thumbnail

Adults Trying to Lose Weight May Overestimate How Healthy Their Diets Are

Pharmacy Times

The American Heart Association issued a dietary guidance in 2021 suggesting that adults consume a variety of fruits and vegetables, choose whole grains instead of refined grains, eat healthy protein sources and lean cuts of meat, and substitute nonfat and low-fat dairy products for full-fat versions, among other measures. us

114
114
article thumbnail

Pandemic boost to decentralised trials is here to stay

Pharma Phorum

Due to the pandemic, decentralised trial solutions made the shift from an emerging trend to a crucial element of drug development. Ben Hargreaves examines the latest research suggesting that this transition looks set to become a permanent feature of trials in the years to come.

article thumbnail

flipMD by GoodRx decreases physician burnout through medical matchmaking

PharmaVoice

Using flipMD, organizations can find, vet, connect with and source practicing board-certified physicians from all specialties for contract, project-based or full-time assignments

83
article thumbnail

CMS seeks to close gaps in health equity data collection as new measures roll out

Fierce Healthcare

CMS seeks to close gaps in health equity data collection as new measures roll out. rking. Fri, 11/11/2022 - 15:32

93
article thumbnail

Current Treatment Landscape for HR+/HER2- Breast Cancer

Pharmacy Times

Dr McHayleh provides an overview of HR+/HER2- breast cancer treatment strategies and practices.

114
114
article thumbnail

Eli Lilly ordered to pay $177M to rival Teva in migraine patent fight

Fierce Pharma

Eli Lilly ordered to pay $177M to rival Teva in migraine patent fight. zbecker. Thu, 11/10/2022 - 11:11

91